カテゴリー： 世界, 医療/バイオ, LP Information

世界の閉塞性尿路疾患治療市場予測 2023年-2029年

【英語タイトル】Global Obstructive Uropathy Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC06637）・商品コード：LP23DC06637
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥519,720見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥779,580見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,039,440見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の閉塞性尿路疾患治療市場」は、過去の販売実績から2022年の世界の閉塞性尿路疾患治療の総販売量を検討し、2023年から2029年の予測される閉塞性尿路疾患治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の閉塞性尿路疾患治療の市場規模を掲載し、XXX百万米ドル規模の世界の閉塞性尿路疾患治療市場の詳細な分析を提供します。本インサイトレポートは、世界の閉塞性尿路疾患治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の閉塞性尿路疾患治療市場における各社の独自のポジションをより深く理解するために、閉塞性尿路疾患治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の閉塞性尿路疾患治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。閉塞性尿路疾患治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。閉塞性尿路疾患治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。閉塞性尿路疾患治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

閉塞性尿路疾患治療の世界主要メーカーとしては、Boston Scientific Corporation、 Olympus Corporation、 Teleflex Incorporated、 B. Braun Melsungen AG、 Applied Medical、 AngioDynamics、 Merit Medical Systems、 Argon Medical Devices, Inc.、 optimed、 Cook Medical、 C. R. Bardなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の閉塞性尿路疾患治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では閉塞性尿路疾患治療市場をセグメンテーションし、種類別 (内科的治療、外科的治療)、用途別 (病院、クリニック、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：内科的治療、外科的治療

・用途別区分：病院、クリニック、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の閉塞性尿路疾患治療市場の10年間の市場状況・展望は？
・世界および地域別に見た閉塞性尿路疾患治療市場成長の要因は何か？
・閉塞性尿路疾患治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・閉塞性尿路疾患治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：閉塞性尿路疾患治療の年間販売量2018-2029、地域別現状・将来分析
・閉塞性尿路疾患治療の種類別セグメント：内科的治療、外科的治療
・閉塞性尿路疾患治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・閉塞性尿路疾患治療の用途別セグメント：病院、クリニック、その他
・閉塞性尿路疾患治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の閉塞性尿路疾患治療市場
・企業別のグローバル閉塞性尿路疾患治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の閉塞性尿路疾患治療の年間売上：2018-2023年の売上、市場シェア
・企業別の閉塞性尿路疾患治療販売価格
・主要企業の閉塞性尿路疾患治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

閉塞性尿路疾患治療の地域別レビュー
・地域別の閉塞性尿路疾患治療市場規模2018-2023：年間販売量、売上
・主要国別の閉塞性尿路疾患治療市場規模2018-2023：年間販売量、売上
・南北アメリカの閉塞性尿路疾患治療販売の成長
・アジア太平洋の閉塞性尿路疾患治療販売の成長
・ヨーロッパの閉塞性尿路疾患治療販売の成長
・中東・アフリカの閉塞性尿路疾患治療販売の成長

南北アメリカ市場
・南北アメリカの国別の閉塞性尿路疾患治療販売量、売上（2018-2023）
・南北アメリカの閉塞性尿路疾患治療の種類別販売量
・南北アメリカの閉塞性尿路疾患治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の閉塞性尿路疾患治療販売量、売上（2018-2023）
・アジア太平洋の閉塞性尿路疾患治療の種類別販売量
・アジア太平洋の閉塞性尿路疾患治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の閉塞性尿路疾患治療販売量、売上（2018-2023）
・ヨーロッパの閉塞性尿路疾患治療の種類別販売量
・ヨーロッパの閉塞性尿路疾患治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の閉塞性尿路疾患治療販売量、売上（2018-2023）
・中東・アフリカの閉塞性尿路疾患治療の種類別販売量
・中東・アフリカの閉塞性尿路疾患治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・閉塞性尿路疾患治療の製造コスト構造分析
・閉塞性尿路疾患治療の製造プロセス分析
・閉塞性尿路疾患治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・閉塞性尿路疾患治療の主要なグローバル販売業者
・閉塞性尿路疾患治療の主要なグローバル顧客

地域別の閉塞性尿路疾患治療市場予測レビュー
・地域別の閉塞性尿路疾患治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・閉塞性尿路疾患治療の種類別市場規模予測
・閉塞性尿路疾患治療の用途別市場規模予測

主要企業分析
Boston Scientific Corporation、 Olympus Corporation、 Teleflex Incorporated、 B. Braun Melsungen AG、 Applied Medical、 AngioDynamics、 Merit Medical Systems、 Argon Medical Devices, Inc.、 optimed、 Cook Medical、 C. R. Bard
・企業情報
・閉塞性尿路疾患治療製品
・閉塞性尿路疾患治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Obstructive Uropathy Treatment market size is projected to grow from US$ 5135.8 million in 2022 to US$ 7317.1 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Obstructive Uropathy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Obstructive Uropathy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Obstructive Uropathy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Obstructive Uropathy Treatment players cover Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Argon Medical Devices, Inc. and optimed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Obstructive uropathy is a disorder of the urinary tract that occurs due to obstructed urinary flow and can be either structural or functional. The back-up of urine into the unilateral or bilateral kidneys, depending on the location of the obstruction, causes hydronephrosis.
LPI (LP Information)’ newest research report, the “Obstructive Uropathy Treatment Industry Forecast” looks at past sales and reviews total world Obstructive Uropathy Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Obstructive Uropathy Treatment sales for 2023 through 2029. With Obstructive Uropathy Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Obstructive Uropathy Treatment industry.
This Insight Report provides a comprehensive analysis of the global Obstructive Uropathy Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Obstructive Uropathy Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Obstructive Uropathy Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Obstructive Uropathy Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Obstructive Uropathy Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Obstructive Uropathy Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Medical Treatement
Surgical Treatment
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Boston Scientific Corporation
Olympus Corporation
Teleflex Incorporated
B. Braun Melsungen AG
Applied Medical
AngioDynamics
Merit Medical Systems
Argon Medical Devices, Inc.
optimed
Cook Medical
C. R. Bard
Key Questions Addressed in this Report
What is the 10-year outlook for the global Obstructive Uropathy Treatment market?
What factors are driving Obstructive Uropathy Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Obstructive Uropathy Treatment market opportunities vary by end market size?
How does Obstructive Uropathy Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Obstructive Uropathy Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Obstructive Uropathy Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Obstructive Uropathy Treatment by Country/Region, 2018, 2022 & 2029
2.2 Obstructive Uropathy Treatment Segment by Type
2.2.1 Medical Treatement
2.2.2 Surgical Treatment
2.3 Obstructive Uropathy Treatment Sales by Type
2.3.1 Global Obstructive Uropathy Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Obstructive Uropathy Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Obstructive Uropathy Treatment Sale Price by Type (2018-2023)
2.4 Obstructive Uropathy Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Obstructive Uropathy Treatment Sales by Application
2.5.1 Global Obstructive Uropathy Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Obstructive Uropathy Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Obstructive Uropathy Treatment Sale Price by Application (2018-2023)
3 Global Obstructive Uropathy Treatment by Company
3.1 Global Obstructive Uropathy Treatment Breakdown Data by Company
3.1.1 Global Obstructive Uropathy Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Obstructive Uropathy Treatment Sales Market Share by Company (2018-2023)
3.2 Global Obstructive Uropathy Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Obstructive Uropathy Treatment Revenue by Company (2018-2023)
3.2.2 Global Obstructive Uropathy Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Obstructive Uropathy Treatment Sale Price by Company
3.4 Key Manufacturers Obstructive Uropathy Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Obstructive Uropathy Treatment Product Location Distribution
3.4.2 Players Obstructive Uropathy Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Obstructive Uropathy Treatment by Geographic Region
4.1 World Historic Obstructive Uropathy Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Obstructive Uropathy Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Obstructive Uropathy Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Obstructive Uropathy Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Obstructive Uropathy Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Obstructive Uropathy Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Obstructive Uropathy Treatment Sales Growth
4.4 APAC Obstructive Uropathy Treatment Sales Growth
4.5 Europe Obstructive Uropathy Treatment Sales Growth
4.6 Middle East & Africa Obstructive Uropathy Treatment Sales Growth
5 Americas
5.1 Americas Obstructive Uropathy Treatment Sales by Country
5.1.1 Americas Obstructive Uropathy Treatment Sales by Country (2018-2023)
5.1.2 Americas Obstructive Uropathy Treatment Revenue by Country (2018-2023)
5.2 Americas Obstructive Uropathy Treatment Sales by Type
5.3 Americas Obstructive Uropathy Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Obstructive Uropathy Treatment Sales by Region
6.1.1 APAC Obstructive Uropathy Treatment Sales by Region (2018-2023)
6.1.2 APAC Obstructive Uropathy Treatment Revenue by Region (2018-2023)
6.2 APAC Obstructive Uropathy Treatment Sales by Type
6.3 APAC Obstructive Uropathy Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Obstructive Uropathy Treatment by Country
7.1.1 Europe Obstructive Uropathy Treatment Sales by Country (2018-2023)
7.1.2 Europe Obstructive Uropathy Treatment Revenue by Country (2018-2023)
7.2 Europe Obstructive Uropathy Treatment Sales by Type
7.3 Europe Obstructive Uropathy Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Obstructive Uropathy Treatment by Country
8.1.1 Middle East & Africa Obstructive Uropathy Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Obstructive Uropathy Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Obstructive Uropathy Treatment Sales by Type
8.3 Middle East & Africa Obstructive Uropathy Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Obstructive Uropathy Treatment
10.3 Manufacturing Process Analysis of Obstructive Uropathy Treatment
10.4 Industry Chain Structure of Obstructive Uropathy Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Obstructive Uropathy Treatment Distributors
11.3 Obstructive Uropathy Treatment Customer
12 World Forecast Review for Obstructive Uropathy Treatment by Geographic Region
12.1 Global Obstructive Uropathy Treatment Market Size Forecast by Region
12.1.1 Global Obstructive Uropathy Treatment Forecast by Region (2024-2029)
12.1.2 Global Obstructive Uropathy Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Obstructive Uropathy Treatment Forecast by Type
12.7 Global Obstructive Uropathy Treatment Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific Corporation
13.1.1 Boston Scientific Corporation Company Information
13.1.2 Boston Scientific Corporation Obstructive Uropathy Treatment Product Portfolios and Specifications
13.1.3 Boston Scientific Corporation Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Corporation Main Business Overview
13.1.5 Boston Scientific Corporation Latest Developments
13.2 Olympus Corporation
13.2.1 Olympus Corporation Company Information
13.2.2 Olympus Corporation Obstructive Uropathy Treatment Product Portfolios and Specifications
13.2.3 Olympus Corporation Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Olympus Corporation Main Business Overview
13.2.5 Olympus Corporation Latest Developments
13.3 Teleflex Incorporated
13.3.1 Teleflex Incorporated Company Information
13.3.2 Teleflex Incorporated Obstructive Uropathy Treatment Product Portfolios and Specifications
13.3.3 Teleflex Incorporated Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teleflex Incorporated Main Business Overview
13.3.5 Teleflex Incorporated Latest Developments
13.4 B. Braun Melsungen AG
13.4.1 B. Braun Melsungen AG Company Information
13.4.2 B. Braun Melsungen AG Obstructive Uropathy Treatment Product Portfolios and Specifications
13.4.3 B. Braun Melsungen AG Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B. Braun Melsungen AG Main Business Overview
13.4.5 B. Braun Melsungen AG Latest Developments
13.5 Applied Medical
13.5.1 Applied Medical Company Information
13.5.2 Applied Medical Obstructive Uropathy Treatment Product Portfolios and Specifications
13.5.3 Applied Medical Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Applied Medical Main Business Overview
13.5.5 Applied Medical Latest Developments
13.6 AngioDynamics
13.6.1 AngioDynamics Company Information
13.6.2 AngioDynamics Obstructive Uropathy Treatment Product Portfolios and Specifications
13.6.3 AngioDynamics Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AngioDynamics Main Business Overview
13.6.5 AngioDynamics Latest Developments
13.7 Merit Medical Systems
13.7.1 Merit Medical Systems Company Information
13.7.2 Merit Medical Systems Obstructive Uropathy Treatment Product Portfolios and Specifications
13.7.3 Merit Medical Systems Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Merit Medical Systems Main Business Overview
13.7.5 Merit Medical Systems Latest Developments
13.8 Argon Medical Devices, Inc.
13.8.1 Argon Medical Devices, Inc. Company Information
13.8.2 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product Portfolios and Specifications
13.8.3 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Argon Medical Devices, Inc. Main Business Overview
13.8.5 Argon Medical Devices, Inc. Latest Developments
13.9 optimed
13.9.1 optimed Company Information
13.9.2 optimed Obstructive Uropathy Treatment Product Portfolios and Specifications
13.9.3 optimed Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 optimed Main Business Overview
13.9.5 optimed Latest Developments
13.10 Cook Medical
13.10.1 Cook Medical Company Information
13.10.2 Cook Medical Obstructive Uropathy Treatment Product Portfolios and Specifications
13.10.3 Cook Medical Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cook Medical Main Business Overview
13.10.5 Cook Medical Latest Developments
13.11 C. R. Bard
13.11.1 C. R. Bard Company Information
13.11.2 C. R. Bard Obstructive Uropathy Treatment Product Portfolios and Specifications
13.11.3 C. R. Bard Obstructive Uropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 C. R. Bard Main Business Overview
13.11.5 C. R. Bard Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Obstructive Uropathy Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Obstructive Uropathy Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Medical Treatement
Table 4. Major Players of Surgical Treatment
Table 5. Global Obstructive Uropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Obstructive Uropathy Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Obstructive Uropathy Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Obstructive Uropathy Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Obstructive Uropathy Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Obstructive Uropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Obstructive Uropathy Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Obstructive Uropathy Treatment Revenue by Application (2018-2023)
Table 13. Global Obstructive Uropathy Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Obstructive Uropathy Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Obstructive Uropathy Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Obstructive Uropathy Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Obstructive Uropathy Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Obstructive Uropathy Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Obstructive Uropathy Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Obstructive Uropathy Treatment Producing Area Distribution and Sales Area
Table 21. Players Obstructive Uropathy Treatment Products Offered
Table 22. Obstructive Uropathy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Obstructive Uropathy Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Obstructive Uropathy Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Obstructive Uropathy Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Obstructive Uropathy Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Obstructive Uropathy Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Obstructive Uropathy Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Obstructive Uropathy Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Obstructive Uropathy Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Obstructive Uropathy Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Obstructive Uropathy Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Obstructive Uropathy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Obstructive Uropathy Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Obstructive Uropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Obstructive Uropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Obstructive Uropathy Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Obstructive Uropathy Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Obstructive Uropathy Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Obstructive Uropathy Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Obstructive Uropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Obstructive Uropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Obstructive Uropathy Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Obstructive Uropathy Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Obstructive Uropathy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Obstructive Uropathy Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Obstructive Uropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Obstructive Uropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Obstructive Uropathy Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Obstructive Uropathy Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Obstructive Uropathy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Obstructive Uropathy Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Obstructive Uropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Obstructive Uropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Obstructive Uropathy Treatment
Table 58. Key Market Challenges & Risks of Obstructive Uropathy Treatment
Table 59. Key Industry Trends of Obstructive Uropathy Treatment
Table 60. Obstructive Uropathy Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Obstructive Uropathy Treatment Distributors List
Table 63. Obstructive Uropathy Treatment Customer List
Table 64. Global Obstructive Uropathy Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Obstructive Uropathy Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Obstructive Uropathy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Obstructive Uropathy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Obstructive Uropathy Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Obstructive Uropathy Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Obstructive Uropathy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Obstructive Uropathy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Obstructive Uropathy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Obstructive Uropathy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Obstructive Uropathy Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Obstructive Uropathy Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Obstructive Uropathy Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Obstructive Uropathy Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boston Scientific Corporation Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Boston Scientific Corporation Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 80. Boston Scientific Corporation Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Boston Scientific Corporation Main Business
Table 82. Boston Scientific Corporation Latest Developments
Table 83. Olympus Corporation Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Olympus Corporation Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 85. Olympus Corporation Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Olympus Corporation Main Business
Table 87. Olympus Corporation Latest Developments
Table 88. Teleflex Incorporated Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Teleflex Incorporated Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 90. Teleflex Incorporated Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Teleflex Incorporated Main Business
Table 92. Teleflex Incorporated Latest Developments
Table 93. B. Braun Melsungen AG Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. B. Braun Melsungen AG Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 95. B. Braun Melsungen AG Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. B. Braun Melsungen AG Main Business
Table 97. B. Braun Melsungen AG Latest Developments
Table 98. Applied Medical Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Applied Medical Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 100. Applied Medical Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Applied Medical Main Business
Table 102. Applied Medical Latest Developments
Table 103. AngioDynamics Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. AngioDynamics Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 105. AngioDynamics Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AngioDynamics Main Business
Table 107. AngioDynamics Latest Developments
Table 108. Merit Medical Systems Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Merit Medical Systems Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 110. Merit Medical Systems Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Merit Medical Systems Main Business
Table 112. Merit Medical Systems Latest Developments
Table 113. Argon Medical Devices, Inc. Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 115. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Argon Medical Devices, Inc. Main Business
Table 117. Argon Medical Devices, Inc. Latest Developments
Table 118. optimed Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. optimed Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 120. optimed Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. optimed Main Business
Table 122. optimed Latest Developments
Table 123. Cook Medical Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Cook Medical Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 125. Cook Medical Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Cook Medical Main Business
Table 127. Cook Medical Latest Developments
Table 128. C. R. Bard Basic Information, Obstructive Uropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. C. R. Bard Obstructive Uropathy Treatment Product Portfolios and Specifications
Table 130. C. R. Bard Obstructive Uropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. C. R. Bard Main Business
Table 132. C. R. Bard Latest Developments
List of Figures
Figure 1. Picture of Obstructive Uropathy Treatment
Figure 2. Obstructive Uropathy Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Obstructive Uropathy Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Obstructive Uropathy Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Obstructive Uropathy Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Medical Treatement
Figure 10. Product Picture of Surgical Treatment
Figure 11. Global Obstructive Uropathy Treatment Sales Market Share by Type in 2022
Figure 12. Global Obstructive Uropathy Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Obstructive Uropathy Treatment Consumed in Hospital
Figure 14. Global Obstructive Uropathy Treatment Market: Hospital (2018-2023) & (K Units)
Figure 15. Obstructive Uropathy Treatment Consumed in Clinic
Figure 16. Global Obstructive Uropathy Treatment Market: Clinic (2018-2023) & (K Units)
Figure 17. Obstructive Uropathy Treatment Consumed in Others
Figure 18. Global Obstructive Uropathy Treatment Market: Others (2018-2023) & (K Units)
Figure 19. Global Obstructive Uropathy Treatment Sales Market Share by Application (2022)
Figure 20. Global Obstructive Uropathy Treatment Revenue Market Share by Application in 2022
Figure 21. Obstructive Uropathy Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Obstructive Uropathy Treatment Sales Market Share by Company in 2022
Figure 23. Obstructive Uropathy Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Obstructive Uropathy Treatment Revenue Market Share by Company in 2022
Figure 25. Global Obstructive Uropathy Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Obstructive Uropathy Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Obstructive Uropathy Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Obstructive Uropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Obstructive Uropathy Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Obstructive Uropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Obstructive Uropathy Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Obstructive Uropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Obstructive Uropathy Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Obstructive Uropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Obstructive Uropathy Treatment Sales Market Share by Country in 2022
Figure 36. Americas Obstructive Uropathy Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Obstructive Uropathy Treatment Sales Market Share by Type (2018-2023)
Figure 38. Americas Obstructive Uropathy Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Obstructive Uropathy Treatment Sales Market Share by Region in 2022
Figure 44. APAC Obstructive Uropathy Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Obstructive Uropathy Treatment Sales Market Share by Type (2018-2023)
Figure 46. APAC Obstructive Uropathy Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Obstructive Uropathy Treatment Sales Market Share by Country in 2022
Figure 55. Europe Obstructive Uropathy Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Obstructive Uropathy Treatment Sales Market Share by Type (2018-2023)
Figure 57. Europe Obstructive Uropathy Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Obstructive Uropathy Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Obstructive Uropathy Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Obstructive Uropathy Treatment Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Obstructive Uropathy Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Obstructive Uropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Obstructive Uropathy Treatment in 2022
Figure 73. Manufacturing Process Analysis of Obstructive Uropathy Treatment
Figure 74. Industry Chain Structure of Obstructive Uropathy Treatment
Figure 75. Channels of Distribution
Figure 76. Global Obstructive Uropathy Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Obstructive Uropathy Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Obstructive Uropathy Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Obstructive Uropathy Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Obstructive Uropathy Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Obstructive Uropathy Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の閉塞性尿路疾患治療市場予測 2023年-2029年] (コード：LP23DC06637)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の閉塞性尿路疾患治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の前立腺がん治療装置市場予測 2023年-2029年
  • 世界の新生児黄疸治療用ベッド市場予測 2023年-2029年
  • 世界の萎縮性膣炎治療市場予測 2023年-2029年
  • 世界の腱板損傷治療装置市場予測 2023年-2029年
  • 世界の静脈性潰瘍用治療市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆